Spanish Cardiac Catheterization and Coronary Intervention Registry. 30th Official Report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2020) in the year of the COVID-19 pandemic


Posted: 2021-11-16 20:00:00
Introduction and objectives: The Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC) presents its annual activity report for 2020, the year of the coronavirus disease (COVID-19) pandemic. Methods: All Spanish centers with catheterization laboratories were invited to participate. Data were collected online and were analyzed by an external company, together with the members of the ACI-SEC. Results: A total of 123 centers participated (4 more than 2019), of which 83 were public and 40 were private. Diagnostic coronary angiograms decreased by 9.4%, percutaneous coronary interventions by 10.1%, primary percutaneous coronary interventions by 4.1%, transcatheter aortic valve replacements by 0.9%, and left atrial appendage closure by 8.3%. The only procedures that increased with respect to previous years were edge-to-edge mitral valve repair (13.8%) and patent foramen ovale closure (19.4%). The use of pressure wire (5.5%), intravascular imaging devices and plaque preparation devices decreased (with the exception of lithotripsy, which increased by 62%). Conclusions: In the year of the COVID-19 pandemic, the registry showed a marked drop in activity in all procedures except for percutaneous mitral valve repair and patent foramen ovale closure. This decrease was less marked than previously described, suggesting a rebound in interventional activity after the first wave. Keywords: Cardiovascular disease; Coronavirus; Drug-eluting stent; Enfermedad cardiovascular; Infarto de miocardio; Myocardial infarction; Stent farmacoactivo.

参考サイト PubMed: covid-19


Powered by Vergleichsportal


バイオクイックニュース日本語版:COVID-19特集

バイオクイックニュース日本語版
6月 17, 2020 バイオアソシエイツ

COVID-19の重症度を予測し、適切な治療コースを指示する可能性のある27のタンパク質バイオマーカーを患者血液の質量分析で特定。

英国のフランシスクリック研究所とシャリテー – ベルリン医科大学の研究者、および他機関の同僚は、 COVID-19 の患者が重症になる可能性が高いかどうかの予測に使用できる27のタンパク質バイオマーカーを特定した。COVID-19を引き起こすRNAウイルスであるSARS-CoV-2に感染した人々は、異なる反応を示す。 この病気は症状が出ない人もいれば、入院が必要な致命的な人もいる。この研究では、2020年6月1日にCell…

ゲスト 514人 と メンバー 2人 がオンラインです